Arena Pharmaceuticals, Inc. (ARNA) Down 12.2% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/25/21
Arena Pharmaceuticals Reports Topline Results from Phase 2b CAPTIVATE Clinical TrialBusiness Wire • 03/02/21
Arena Pharmaceuticals Inc.'s (ARNA) CEO Amit Munshi on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/24/21
Arena Reports Fourth Quarter Financial Results with Strong Liquidity Position and Maintained Pipeline Progress Over the QuarterBusiness Wire • 02/23/21
Arena Pharmaceuticals to Release Fourth Quarter & Full-Year 2020 Financial Results and Provide Corporate Update on February 23Business Wire • 02/16/21
Arena Pharmaceuticals Completes Full Enrollment of Etrasimod Phase 3 ELEVATE UC 52 TrialBusiness Wire • 02/02/21
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 39th Annual J.P. Morgan Healthcare Conference (Transcript)Seeking Alpha • 01/13/21
Arena Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference on January 13PRNewsWire • 12/22/20
Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial - Late-Breaker at Revolutionizing Atopic Dermatitis ConferencePRNewsWire • 12/11/20
Arena Pharmaceuticals, Inc. (ARNA) CEO Amit Munshi Presents at 3rd Annual Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 12/02/20